145 related articles for article (PubMed ID: 24996831)
1. Quality of life and sexual function in patients with borderline tumors of the ovary. A substudy of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) study group ROBOT study.
Farthmann J; Hasenburg A; Weil M; Fotopoulou C; Ewald-Riegler N; du Bois O; Trillsch F; Mahner S; Strauss HG; Wimberger P; Reuss A; du Bois A
Support Care Cancer; 2015 Jan; 23(1):117-23. PubMed ID: 24996831
[TBL] [Abstract][Full Text] [Related]
2. Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study.
Trillsch F; Mahner S; Woelber L; Vettorazzi E; Reuss A; Ewald-Riegler N; de Gregorio N; Fotopoulou C; Schmalfeldt B; Burges A; Hilpert F; Fehm T; Meier W; Hillemanns P; Hanker L; Hasenburg A; Strauss HG; Hellriegel M; Wimberger P; Baumann K; Keyver-Paik MD; Canzler U; Wollschlaeger K; Forner D; Pfisterer J; Schroeder W; Muenstedt K; Richter B; Kommoss F; Hauptmann S; du Bois A
Ann Oncol; 2014 Jul; 25(7):1320-1327. PubMed ID: 24618151
[TBL] [Abstract][Full Text] [Related]
3. The effect of fertility-sparing surgery on sexuality and global quality of life in women with malignant ovarian germ cell and sex cord stromal tumors: an analysis of the CORSETT database of the AGO study group.
Hasenburg A; Plett H; Krämer B; Braicu E; Czogalla B; Bossart M; Singer S; Mayr D; Staebler A; du Bois A; Kommoss S; Link T; Burges A; Heitz F; Keul J; Trillsch F; Harter P; Wimberger P; Buderath P; Klar M
Arch Gynecol Obstet; 2021 Dec; 304(6):1541-1549. PubMed ID: 34287678
[TBL] [Abstract][Full Text] [Related]
4. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; D'argent Mathieu E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101966. PubMed ID: 33144266
[TBL] [Abstract][Full Text] [Related]
5. Sexual satisfaction and quality of life in survivors of localized cervical and ovarian cancers following fertility-sparing surgery.
Chan JL; Letourneau J; Salem W; Cil AP; Chan SW; Chen LM; Rosen MP
Gynecol Oncol; 2015 Oct; 139(1):141-7. PubMed ID: 26232519
[TBL] [Abstract][Full Text] [Related]
6. Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group.
du Bois A; Ewald-Riegler N; de Gregorio N; Reuss A; Mahner S; Fotopoulou C; Kommoss F; Schmalfeldt B; Hilpert F; Fehm T; Burges A; Meier W; Hillemanns P; Hanker L; Hasenburg A; Strauss HG; Hellriegel M; Wimberger P; Keyver-Paik MD; Baumann K; Canzler U; Wollschlaeger K; Forner D; Pfisterer J; Schröder W; Münstedt K; Richter B; Kommoss S; Hauptmann S;
Eur J Cancer; 2013 May; 49(8):1905-14. PubMed ID: 23490647
[TBL] [Abstract][Full Text] [Related]
7. Fertility-sparing surgery and reproductive-outcomes in patients with borderline ovarian tumors.
Plett H; Harter P; Ataseven B; Heitz F; Prader S; Schneider S; Heikaus S; Fisseler-Eckhoff A; Kommoss F; Lax SF; Staebler A; Traut A; du Bois A
Gynecol Oncol; 2020 May; 157(2):411-417. PubMed ID: 32115229
[TBL] [Abstract][Full Text] [Related]
8. Identification of factors that impact recurrence in patients with borderline ovarian tumors.
Chen X; Fang C; Zhu T; Zhang P; Yu A; Wang S
J Ovarian Res; 2017 Apr; 10(1):23. PubMed ID: 28376898
[TBL] [Abstract][Full Text] [Related]
9. Quality of life and sexuality comparison between sexually active ovarian cancer survivors and healthy women.
Kim SI; Lee Y; Lim MC; Joo J; Park K; Lee DO; Park SY
J Gynecol Oncol; 2015 Apr; 26(2):148-54. PubMed ID: 25686396
[TBL] [Abstract][Full Text] [Related]
10. Sexual Activity and Function in Patients With Gynecological Malignancies After Completed Treatment.
Grimm D; Hasenburg A; Eulenburg C; Steinsiek L; Mayer S; Eltrop S; Prieske K; Trillsch F; Mahner S; Woelber L
Int J Gynecol Cancer; 2015 Jul; 25(6):1134-41. PubMed ID: 26098093
[TBL] [Abstract][Full Text] [Related]
11. LION-PAW (lymphadenectomy in ovarian neoplasm) sexual function assessment: a prospective sub-study of the LION trial.
Hasenburg A; Sehouli J; Lampe B; Reuss A; Schmalfeld B; Belau AK; Bossart M; Mahner S; Hillemanns P; Petry U; du Bois A; Herwig U; Hilpert F; Gropp-Meier M; Hanf V; Greimel E; Wagner U; Harter P
Int J Gynecol Cancer; 2020 Oct; 30(10):1548-1553. PubMed ID: 32938723
[TBL] [Abstract][Full Text] [Related]
12. Fertility and prognosis of borderline ovarian tumor after conservative management: Results of the multicentric OPTIBOT study by the GINECO & TMRG group.
Chevrot A; Pouget N; Bats AS; Huchon C; Guyon F; Chopin N; Rousset-Jablonski C; Beurrier F; Lambaudie E; Provansal M; Sabatier R; Heinemann M; Ngo C; Bonsang-Kitzis H; Lecuru F; Bailly E; Ferron G; Cornou C; Lardin E; Leblanc E; Philip CA; Ray-Coquard I; Hequet D
Gynecol Oncol; 2020 Apr; 157(1):29-35. PubMed ID: 32241341
[TBL] [Abstract][Full Text] [Related]
13. Young women diagnosed with early-stage ovarian cancer or borderline malignancy of the ovary: a focus on fertility and sexual function.
Campos SM; Berlin S; Matulonis UA; Muto MG; Pereira L; Mosquera MM; Horowitz N
J Psychosoc Oncol; 2012; 30(4):387-401. PubMed ID: 22747104
[TBL] [Abstract][Full Text] [Related]
14. Sexual activity and quality of life in patients after treatment for breast and ovarian cancer.
Mayer S; Iborra S; Grimm D; Steinsiek L; Mahner S; Bossart M; Woelber L; Voss PJ; Gitsch G; Hasenburg A
Arch Gynecol Obstet; 2019 Jan; 299(1):191-201. PubMed ID: 30386993
[TBL] [Abstract][Full Text] [Related]
15. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Therapeutic Management of Early Stages].
Canlorbe G; Lecointre L; Chauvet P; Azaïs H; Fauvet R; Uzan C
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):287-303. PubMed ID: 32004786
[TBL] [Abstract][Full Text] [Related]
16. Borderline Ovarian Tumors: Fifteen Years' Experience at a Scottish Tertiary Cancer Center.
May J; Skorupskaite K; Congiu M; Ghaoui N; Walker GA; Fegan S; Martin CW; O'Donnell RL
Int J Gynecol Cancer; 2018 Nov; 28(9):1683-1691. PubMed ID: 30365457
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological analysis of borderline ovarian tumours and risk factors related to recurrence: experience of single institution.
Sozen H; Vatansever D; Topuz S; Iyibozkurt C; Kandemir H; Yalçin I; Onder S; Yavuz E; Salihoglu Y
J Obstet Gynaecol; 2019 Feb; 39(2):253-258. PubMed ID: 30372646
[TBL] [Abstract][Full Text] [Related]
18. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.
Yang ZJ; Liu ZC; Wei RJ; Li L
Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958
[TBL] [Abstract][Full Text] [Related]
19. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Surgical Management of Advanced Stages of Borderline Ovarian Tumours].
Raimond E; Bourdel N
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):304-313. PubMed ID: 32004785
[TBL] [Abstract][Full Text] [Related]
20. Borderline ovarian tumors: outcomes of fertility sparing surgery.
Ozalp SS; Yalcin OT; Telli E; Oge T; Kabukcuoglu S
Eur J Gynaecol Oncol; 2014; 35(2):154-6. PubMed ID: 24772918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
